Neuropeptide b and w-receptor as a target for treating mood disorders and / or chronic stress

EP4766368A1Pending Publication Date: 2026-07-01FRIEDRICH SCHILLER UNIV JENA
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
FRIEDRICH SCHILLER UNIV JENA
Filing Date
2024-08-20
Publication Date
2026-07-01

Smart Images

  • Figure IMGF000040_0001
    Figure IMGF000040_0001
  • Figure IMGF000043_0001
    Figure IMGF000043_0001
  • Figure IMGF000044_0001
    Figure IMGF000044_0001
Patent Text Reader

Abstract

Described is a pharmaceutical composition comprising an antagonist / inhibitor of neuropeptide B / W receptor (NPBWR1) for use in in a method of treating, ameliorating or preventing a mood disorder / affective disorder and / or chronic stress and / or anxiety disorders and / or Parkinson's disease. Moreover, described is a pharmaceutical composition comprising an agonist / activator of neuropeptide B / W receptor (NPBWR1) for use in in a method of treating, ameliorating or preventing a bipolar affective disorder (ICD-10 F31) during the manic phase, appetitive disorders, preferably anorexia or bulimia. Further, described is a method for assessing the activity of a candidate molecule suspected of being an antagonist / inhibitor or an agonist / activator of NPBWR1.
Need to check novelty before this filing date? Find Prior Art